What is erythromelalgia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Erythromelalgia?

Erythromelalgia is a rare neurovascular disorder characterized by episodic burning pain associated with redness, warmth, and increased temperature of the extremities, most commonly affecting the feet and hands. 1

Clinical Characteristics

The condition presents with a classic triad of symptoms that occur in episodes:

  • Intense burning pain primarily in the feet, less frequently in the hands 2
  • Erythema (redness) of the affected skin during symptomatic episodes 1, 2
  • Warmth and increased temperature of the extremities 1, 3
  • Swelling may be present during symptoms, though not universally reported 1

Triggering Factors and Relief

Episodes are characteristically triggered by specific circumstances:

  • Physical activity and exercise commonly precipitate symptoms 1, 4
  • Exposure to warm temperatures or increased ambient heat 1, 3
  • Pain is relieved by cooling the affected areas, which patients often accomplish through ice water immersion or fans 1

Classification: Primary vs Secondary

Primary (Inherited) Erythromelalgia

  • Accounts for approximately 5% of cases with identifiable genetic mutations in the SCN9A gene 4
  • These gain-of-function variants cause Nav1.7 sodium channels to open more easily and stay open longer, resulting in prolonged neuronal activation and disproportionate pain 4
  • Some familial cases occur without detectable SCN9A variants, suggesting other genes are involved 4, 2
  • Strongly associated with small fiber neuropathy, with marked abnormalities on thermoregulatory sweat testing in approximately 90% of patients 4

Secondary Erythromelalgia

  • Myeloproliferative disorders (essential thrombocythemia, polycythemia vera) are present in approximately 5% of cases 4, 5
  • Pathogenesis involves platelet-mediated endothelial cell injury resulting in inflammation and transient thrombotic occlusion 4
  • Autoimmune conditions such as systemic lupus erythematosus can trigger secondary forms 4
  • Certain medications including calcium channel blockers and ergot derivatives may precipitate the condition 4, 6

Clinical Impact and Complications

This is not merely a benign condition—it significantly affects patient outcomes:

  • Lower quality of life compared to the general population 1
  • Increased morbidity and mortality 1
  • Increased risk for suicide due to severe, unrelenting pain 1
  • Patients may engage in extreme cooling behaviors that lead to tissue damage, ulcerations, immersion foot, or trench foot 1

Diagnostic Challenges

Because symptoms are intermittent and extremities may appear normal during consultation, the diagnosis is frequently missed. 1 Patients often self-diagnose or seek help across multiple specialties including primary care, dermatology, vascular medicine, neurology, and pain medicine before receiving the correct diagnosis 1.

Pathophysiological Mechanisms

The underlying mechanisms involve:

  • Endogenous temperature control dysfunction, likely through vasodilation of thermoregulatory arteriovenous anastomoses 1
  • Small fiber neuropathy is present in approximately 90% of patients on thermoregulatory sweat testing 4
  • Large fiber neuropathy is found on electromyography and nerve conduction studies in almost 50% of patients 4
  • A bidirectional relationship between neuropathy and erythromelalgia may exist 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Erythromelalgia Diagnosis and Evaluation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Secondary erythromelalgia - a case report -.

The Korean journal of pain, 2013

Guideline

Erythromelalgia Causes and Mechanisms

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Erythromelalgia--a thrombotic complication in chronic myeloproliferative disorders.

Medical science monitor : international medical journal of experimental and clinical research, 2000

Research

[Erythromelalgia: Diagnosis and therapeutic approach].

La Revue de medecine interne, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.